Enzyme Polymorphism Effects

Enzyme Polymorphism Effects is a pharmacogenetic phenomenon in phase II metabolism wherein interindividual genetic variations in enzyme-coding genes result in altered enzymatic activity, thereby affecting the biotransformation efficiency and pharmacokinetic profile of xenobiotics.

399

Publications

19.5K

Citations

2K

Authors

652

Institutions

Publications per year

2017–2026

19

Authors

2K

  1. IT
    Ikiko Tsuritani

    Kanazawa Medical University, Japan

    4 publications · 170 citations

    4

    h-index

  2. GB
    George B. Johnson

    Washington University in St. Louis, United States

    4 publications · 190 citations

    4

    h-index

  3. FC
    François Cambien

    Inserm, France

    3 publications · 484 citations

    3

    h-index

  4. FS
    Fang Sun

    Columbia University, United States

    3 publications · 129 citations

    3

    h-index

  5. RM
    Richard M. Weinshilboum

    Mayo Clinic, United States

    3 publications · 630 citations

    3

    h-index

1–5 of 2K

Venues

  1. PubMed

    Repository · 31 publications · 1.2K citations

    19

    h-index

  2. Biochemical Genetics

    10 publications · 262 citations

    10

    h-index

  3. American Journal of Hypertension

    AJH · 9 publications · 330 citations

    9

    h-index

  4. Human Genetics

    9 publications · 402 citations

    9

    h-index

  5. Journal of Hypertension

    7 publications · 388 citations

    7

    h-index

1–5